Videos de Experimentos Relacionados

Terapia con interferón beta para la esclerosis múltiple.

D E Goodkin¹

¹MS Center, Department of Neurology, University of California San Francisco, 94115, USA.

Lancet (London, England)

|November 20, 1998

Resumen

No abstract available in PubMed .

Videos de Conceptos Relacionados

También podría leer

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por

Same author

MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy.

Journal of neurology, neurosurgery, and psychiatry·2003

Same author

T2 relaxation time histograms in multiple sclerosis.

Magnetic resonance imaging·2003

Same author

3-D echo planar (1)HMRS imaging in MS: metabolite comparison from supratentorial vs. central brain.

Magnetic resonance imaging·2002

Videos de Experimentos Relacionados

Terapia con interferón beta para la esclerosis múltiple.

Videos de Conceptos Relacionados

MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy.

T2 relaxation time histograms in multiple sclerosis.

3-D echo planar (1)HMRS imaging in MS: metabolite comparison from supratentorial vs. central brain.

Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS.

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. 1997.

Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis.

Videos de Experimentos Relacionados

Terapia con interferón beta para la esclerosis múltiple.

Videos de Conceptos Relacionados

MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy.

T2 relaxation time histograms in multiple sclerosis.

3-D echo planar (1)HMRS imaging in MS: metabolite comparison from supratentorial vs. central brain.

Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS.

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. 1997.

Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis.

Videos de Experimentos Relacionados

Terapia con interferón beta para la esclerosis múltiple.

Videos de Conceptos Relacionados

Artículos Relacionados

MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy.

T2 relaxation time histograms in multiple sclerosis.

3-D echo planar (1)HMRS imaging in MS: metabolite comparison from supratentorial vs. central brain.

Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS.

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. 1997.

Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis.

Videos de Experimentos Relacionados

Terapia con interferón beta para la esclerosis múltiple.

Videos de Conceptos Relacionados

Artículos Relacionados

MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy.

T2 relaxation time histograms in multiple sclerosis.

3-D echo planar (1)HMRS imaging in MS: metabolite comparison from supratentorial vs. central brain.

Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS.

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. 1997.

Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis.